Tango Therapeutics, Inc. · NASDAQ:TNGX

Crystal Adam sold 27,000 Tango Therapeutics, Inc. shares (Form 4)

Traded Oct 1, 2026 · Filed Oct 5, 2026

On Oct 1, 2026, Crystal Adam (President, R&D) sold 27,000 Tango Therapeutics, Inc. shares at an average US$24.47 for US$661K under a trading plan, leaving 115,743 shares. Filed Oct 5, 2026 (Form 4).

Sold: 27,000 shares
Price: US$24.47 average (US$24.45 to US$25.32)
Value: US$661K
Holding after: 115,743 shares
Trading plan: Yes (Made under a plan set in advance)
Role: President, R&D

The filing in full

Date	Security	Transaction	Shares	Price	Holding after	Ownership
Oct 1, 2026	Common Stock	Option exercise	27,000	US$5.20	142,743	Direct
Oct 1, 2026	Common Stock	Sale	26,400	US$24.45	116,343	Direct
Oct 1, 2026	Common Stock	Sale	600	US$25.32	115,743	Direct

Source

View original at SEC

Related